Oral cannabinoids in people living with HIV on effective antiretroviral therapy: CTN PT028—study protocol for a pilot randomised trial to assess safety, tolerability and effect on immune activation

INTRODUCTION: Despite antiretroviral therapy (ART), people living with HIV have higher rates of non-infectious chronic diseases. These conditions are driven by relatively high levels of inflammation persisting on ART compared with uninfected individuals. Chronic inflammation also contributes to HIV...

Descripción completa

Detalles Bibliográficos
Autores principales: Costiniuk, Cecilia T, Saneei, Zahra, Routy, Jean-Pierre, Margolese, Shari, Mandarino, Enrico, Singer, Joel, Lebouché, Bertrand, Cox, Joseph, Szabo, Jason, Brouillette, Marie-Josée, Klein, Marina B, Chomont, Nicolas, Jenabian, Mohammad-Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
HIV/AIDS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6340429/
https://www.ncbi.nlm.nih.gov/pubmed/30659041
http://dx.doi.org/10.1136/bmjopen-2018-024793

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6340429/
https://www.ncbi.nlm.nih.gov/pubmed/30659041
http://dx.doi.org/10.1136/bmjopen-2018-024793

Ejemplares similares